Elastic staining-a rejuvenated method to reassess prognosis and serosal invasion in patients with pT3N0M0 gastric cancer

被引:1
|
作者
Lei, Guang [1 ,2 ]
Yang, Haiyan [1 ]
Hong, Ting [2 ]
Zhou, Chunhua [1 ]
Li, Jigang [3 ]
Liu, Wenbin [3 ]
Hu, Jun [3 ]
Zeng, Liang [3 ]
Chen, Gong [1 ,2 ]
Chen, Qiong [1 ,2 ]
Zhang, Yongchang [1 ]
Yang, Nong [1 ]
机构
[1] Xiangya Sch Med, Affiliated Canc Hosp, Hunan Canc Hosp, Dept Med Oncol,Lung Canc & Gastrointestinal Unit, Changsha 410013, Hunan, Peoples R China
[2] Univ South China, Grad Sch, Hengyang 421001, Hunan, Peoples R China
[3] Xiangya Sch Med, Affiliated Canc Hosp, Hunan Canc Hosp, Dept Pathol, Changsha 410013, Hunan, Peoples R China
基金
湖南省自然科学基金;
关键词
Elastic staining; Elastic lamina invasion; pT3N0M0 gastric cancer; Serosal invasion; Prognostic factor; COLORECTAL-CANCER; DIAGNOSTIC-UTILITY; LAMINAL INVASION;
D O I
10.1016/j.humpath.2017.04.023
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prognosis of pT3N0M0 gastric cancer (GC) varies greatly, though the major factor conferring poor prognosis is unclear. Subserosal elastic lamina invasion (ELI+) is Closely associated with poor outcomes in pT3 colorectal cancer, but related research on GC is unavailable. This study aimed to identify the influence of ELI+ on the prognosis of patients with pT3N0M0 GC and its relationship with serosal invasion using elastic staining. We retrospectively reviewed 94 and 28 patients with pT3N0M0 and pT4aN0M0 GC who underwent gastrectomy between 1994 and 2005. For the former, one section with invasion depth closest to the peritoneal surface and one corresponding paraffin block for each specimen were selected for conventional elastic staining to assess the relationship between ELI+ and patients' clinical characteristics and survival. pT3N0M0 GC specimens were divided into 3 groups based on staining results: ELI+ (N = 51), rion-invasion (N = 31), and unidentified (N = 12). ELI+ was closely related to recurrence and lymphoVascular invasion. Five-year disease-free (DFS) (46%) and overall (OS) (36%) survival rates were significantly lower in the ELI+ than in the non-invasion or unidentified groups (P <.0001); no obvious difference was found between the ELI+ and pT4aN0M0 groups (P =.25). Multivariate analysis showed ELI+ and recurrence as independent prognostic factors for DFS in pT3 GC patients. In conclusion, elastic staining is an effective and highly feasible method for predicting prognosis and evaluating the serosal invasion depth ofpT3 GC. pT3 GC accompanied with ELI+ is an obvious adverse prognostic factor and could be considered a treatment for pT4a GC. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 50 条
  • [1] Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
    Lei, Guang
    Yang, Haiyan
    Hong, Ting
    Zhang, Xiangyu
    Yang, Nong
    Zhang, Yongchang
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (147):
  • [2] Predictive value of preoperative routine examination for the prognosis of patients with pT2N0M0 or pT3N0M0 colorectal cancer
    Jing, Peng-Fei
    Chen, Jin
    Yu, En-Da
    Miao, Chao-Yu
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (06)
  • [3] Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
    Huang, Jiao-Bao
    Lu, Jun
    Wu, Dong
    Xu, Bin-bin
    Xue, Zhen
    Lin, Guo-Sheng
    Zheng, Hua-Long
    Shen, Li-Li
    Lin, Jia
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lin, Jian-Xian
    Chen, Qi-Yue
    Cao, Long-Long
    Zheng, Chao-Hui
    Huang, Chang-Ming
    Li, Ping
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Adjuvant Chemotherapy vs. Surgery Alone for pT3N0M0 Gastric Cancer
    Kang, Minseo
    Youn, Ho Geun
    An, Ji Yeong
    Choi, Min-Gew
    Lee, Jun Ho
    Sohn, Tae Sung
    Bae, Jae Moon
    Kim, Sung
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1437 - 1444
  • [5] Adjuvant Chemotherapy vs. Surgery Alone for pT3N0M0 Gastric Cancer
    Minseo Kang
    Ho Geun Youn
    Ji Yeong An
    Min-Gew Choi
    Jun Ho Lee
    Tae Sung Sohn
    Jae Moon Bae
    Sung Kim
    [J]. Annals of Surgical Oncology, 2021, 28 : 1437 - 1444
  • [6] Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy
    Li, Chunyan
    Wang, Jiangfeng
    Mo, Miao
    Yuan, Jing
    Luo, Jurui
    Jin, Kairui
    Wang, Xuanyi
    Yang, Yilan
    Ma, Jinli
    Mei, Xin
    Yang, Zhaozhi
    Yu, Xiaoli
    Guo, Xiaomao
    Chen, Xingxing
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3889 - 3899
  • [7] Identification of candidates for postmastectomy radiotherapy in patients with pT3N0M0 breast cancer
    Hamamoto, Yasushi
    Ohsumi, Shozo
    Aogi, Kenjiro
    Takashima, Shigemitsu
    Shinohara, Shuichi
    Nakajima, Naomi
    Kataoka, Masaaki
    [J]. BREAST CANCER, 2013, 20 (03) : 218 - 222
  • [8] pT3N0M0 prostate cancer: a plea for adjuvant radiation
    Michel Bolla
    Laurence Collette
    [J]. Nature Reviews Urology, 2009, 6 : 410 - 412
  • [9] Identification of candidates for postmastectomy radiotherapy in patients with pT3N0M0 breast cancer
    Yasushi Hamamoto
    Shozo Ohsumi
    Kenjiro Aogi
    Shigemitsu Takashima
    Shuichi Shinohara
    Naomi Nakajima
    Masaaki Kataoka
    [J]. Breast Cancer, 2013, 20 : 218 - 222
  • [10] A nomogram for predicting cancer specific survival (CSS) in patients with pathological T3N0M0 (pT3N0M0) rectal cancer
    Liu, Shuang
    Xi, ShaoYan
    Wu, Xiao-Jun
    Cai, Peiqiang
    Ding, Pei-Rong
    Chen, Gong
    Pan, Zhi-Zhong
    Gao, Yuan-Hong
    Xiao, Weiwei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)